The Cancer Research Institute Associate Board is a group of young leaders dedicated to CRI and its mission to advance cancer immunotherapy research. Members provide invaluable professional expertise and utilize their diverse talents to develop social events, assist with fundraising initiatives, and cultivate individual and corporate relationships.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We spoke with Susanne Baumeister, M.D., about the current treatment landscape in childhood cancer, including immunotherapy and clinical trial options.
Dr. Michel Sadelain discusses what’s next in CAR T cell therapy, including the remarkable benefits and the challenges ahead for this incredibly promising immunotherapy approach.